Market Overview:
The global pediatric influenza treatment market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of pediatric influenza, rising demand for better and faster-acting antiviral drugs, and growing awareness about preventive measures against pediatric influenza. The global pediatric influenza treatment market is segmented on the basis of type into antiviral drugs, antipyretics, neuraminidase inhibitors, and others. The antiviral drug segment is expected to account for the largest share of the global pediatric influenza treatment market in 2018 owing to its high efficacy in treating pediatric flu infections. The antipyretic segment is projected to grow at a higher CAGR than other segments during the forecast period due to its ability to provide relief from fever associated with flu infection. On the basis of application, hospitals are expected to account for the largest share of the global pediatric influenza treatment market in 2018 followed by clinics and ambulatory surgical centers (ASCs). Rising demand for better healthcare facilities among parents has led hospitals emerge as key players in providing paediatric care services including diagnosis and treatment of paediatric flu infections.
Product Definition:
Pediatric Influenza Treatment is a type of medication that is used to help treat pediatric patients who are suffering from the flu. This treatment can help to lessen the symptoms of the flu and can also help to shorten the length of time that a patient is sick. The importance of Pediatric Influenza Treatment lies in its ability to help children recover from the flu more quickly, which can prevent further illness and potential complications.
Antiviral Drug:
Antiviral drug is a medication used to reduce or prevent the replication of viruses in infected cells. The most commonly used antiviral drugs are called the neuraminidase inhibitors (NAIs). Other important classes of drugs include but are not limited to, protease inhibitors, non-nucleoside reverse transcriptase inhibitors and entry blockers.
Antipyretic:
Antipyretics are drugs that prevent pyrexia (fever) in patients. They are used to treat influenza, and its complications including myocardial infarction, stroke, renal failure and others. Antipyretics act by elevating the body temperature which helps kill the viruses.
Global Antipyretic Market Size & Forecasts To 2024 -> The global antipyretic market was valued at USD 1.8 billion in 2015.
Application Insights:
Based on application, the global market is segmented into hospitals, clinics, ambulatory surgical centers and others. The clinics segment dominated the overall market in terms of revenue in 2017. This can be attributed to growing demand for effective treatment options against influenza at minimal cost as well as easy access to these facilities due to widespread distribution channels such as retail pharmacies and online stores that sell medicines directly to the customers.
The hospital segment is expected to witness lucrative growth over the forecast period owing to rising incidences of severe infections caused by seasonal flu viruses every year since childhood immunization against this disease has become a part of routine pediatric care resulting in high demand for its prevention during this time period.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. This can be attributed to the presence of a large number of leading players, high purchasing power, and favorable government initiatives. In addition, increasing cases of pediatric influenza are also contributing towards growth. For instance, as per an article published by NCBI on February 28th 2018; around 10% to 20% more children suffer from influenza like symptoms every year during December-January period than other seasons which is a major factor for concern among parents and hence increases treatment demand.
Infectious Diseases epidemiology has been changing due to globalization.
Growth Factors:
- Increasing incidence of pediatric influenza
- Rising demand for better and faster-acting treatments for pediatric influenza
- Growing awareness about the benefits of early treatment of pediatric influenza
- Increasing number of research and development activities focused on pediatric influenza treatment
- Technological advancements in the field of pediatric influenza treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Pediatric Influenza Treatment Market Research Report
By Type
Antiviral Drug, Antipyretic, Neuraminidase inhibitor, Others
By Application
Hospitals, Clinics, Ambulatory Surgical Centers, Others
By Companies
F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc., NATCO Pharma Limited., NESHER PHARMS, Johnson & Johnsons Inc., Cipla, Hetero Pharma, Teva Pharmaceutical pvt. Ltd., Olainfarm JSC, Gilead Sciences, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Pediatric Influenza Treatment Market Report Segments:
The global Pediatric Influenza Treatment market is segmented on the basis of:
Types
Antiviral Drug, Antipyretic, Neuraminidase inhibitor, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline Plc.
- NATCO Pharma Limited.
- NESHER PHARMS
- Johnson & Johnsons Inc.
- Cipla
- Hetero Pharma
- Teva Pharmaceutical pvt. Ltd.
- Olainfarm JSC
- Gilead Sciences, Inc.
Highlights of The Pediatric Influenza Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antiviral Drug
- Antipyretic
- Neuraminidase inhibitor
- Others
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pediatric Influenza Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pediatric Influenza Treatment is a course of antiviral medications prescribed to children 6 months of age and older who are experiencing symptoms of the flu. Treatment usually lasts for 7 days, but may be shortened if the childu2019s condition improves.
Some of the major players in the pediatric influenza treatment market are F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc., NATCO Pharma Limited., NESHER PHARMS, Johnson & Johnsons Inc., Cipla, Hetero Pharma, Teva Pharmaceutical pvt. Ltd., Olainfarm JSC, Gilead Sciences, Inc..
The pediatric influenza treatment market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pediatric Influenza Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pediatric Influenza Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pediatric Influenza Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pediatric Influenza Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pediatric Influenza Treatment Market Size & Forecast, 2018-2028
4.5.1 Pediatric Influenza Treatment Market Size and Y-o-Y Growth
4.5.2 Pediatric Influenza Treatment Market Absolute $ Opportunity
Chapter 5 Global Pediatric Influenza Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pediatric Influenza Treatment Market Size Forecast by Type
5.2.1 Antiviral Drug
5.2.2 Antipyretic
5.2.3 Neuraminidase inhibitor
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pediatric Influenza Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pediatric Influenza Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pediatric Influenza Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pediatric Influenza Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pediatric Influenza Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Pediatric Influenza Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pediatric Influenza Treatment Market Size Forecast by Type
9.6.1 Antiviral Drug
9.6.2 Antipyretic
9.6.3 Neuraminidase inhibitor
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pediatric Influenza Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pediatric Influenza Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Pediatric Influenza Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pediatric Influenza Treatment Market Size Forecast by Type
10.6.1 Antiviral Drug
10.6.2 Antipyretic
10.6.3 Neuraminidase inhibitor
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pediatric Influenza Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pediatric Influenza Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pediatric Influenza Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pediatric Influenza Treatment Market Size Forecast by Type
11.6.1 Antiviral Drug
11.6.2 Antipyretic
11.6.3 Neuraminidase inhibitor
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pediatric Influenza Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pediatric Influenza Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Pediatric Influenza Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pediatric Influenza Treatment Market Size Forecast by Type
12.6.1 Antiviral Drug
12.6.2 Antipyretic
12.6.3 Neuraminidase inhibitor
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pediatric Influenza Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pediatric Influenza Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pediatric Influenza Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pediatric Influenza Treatment Market Size Forecast by Type
13.6.1 Antiviral Drug
13.6.2 Antipyretic
13.6.3 Neuraminidase inhibitor
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pediatric Influenza Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pediatric Influenza Treatment Market: Competitive Dashboard
14.2 Global Pediatric Influenza Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F. Hoffmann-La Roche Ltd
14.3.2 GlaxoSmithKline Plc.
14.3.3 NATCO Pharma Limited.
14.3.4 NESHER PHARMS
14.3.5 Johnson & Johnsons Inc.
14.3.6 Cipla
14.3.7 Hetero Pharma
14.3.8 Teva Pharmaceutical pvt. Ltd.
14.3.9 Olainfarm JSC
14.3.10 Gilead Sciences, Inc.
